ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2023, Vol. 32 ›› Issue (2): 189-194.DOI: 10.3969/j.issn.1006-298X.2023.02.018

• • 上一篇    下一篇

美国质量激励计划对我国血液透析质量管理的启示和思考

方丽, 杨俊伟   

  • 出版日期:2023-04-28 发布日期:2023-04-24

The enlightenment and thoughts of Quality Incentive Program in America bringing to the quality control management for hemodialysis in China

FANG Li, YANG Junwei   

  • Online:2023-04-28 Published:2023-04-24

摘要: 目前,终末期肾病患者的数量激增和血液透析(HD)需求的逐步增加,迎来了HD市场发展的黄金机遇,同时也给我国医保财政、医疗资源和医疗市场的质量监督管理等带来巨大冲击和严峻挑战——HD医保投入与质量绩效间的成本效益比必将成为未来医疗体制改革的一个重大议题。本文纵览美国透析产业发展史,简要介绍质量激励计划的演变和内涵,建议以质量激励计划为参考、去粗取精,结合我国的实际情况,加强建设我国的HD质量控制数据系统,以质量控制与监督管理的标准化体系建设为核心推动HD的医疗体制改革,实现我国HD的规范发展和最优社会效益。

关键词:

Abstract: Currently, the Chinese hemodialysis market is encountering a great growth opportunity; but meanwhile, the challenges in controlling medicare spending, allocating medical source, and improving quality may also be encountered. Therefore, how to juggle healthcare quality and hemodialysis services payment will certainly be a great topic in Health Care Policy and Reform soon. Herein, we looked back on the changes of US. End-stage kidney disease program over the past 50 years and descripted the Quality Incentive Program in detail. Using Quality Incentive Program as reference, we recommended to construct our hemodialysis quality control data system to supervise the hemodialysis quality-of-care indicators. Constructing the Merit-Based Incentive Payment System might be a good approach to promote the reform of China medical care system and hemodialysis industry.


Key words: hemodialysis, end stage kidney disease, quality Incentive program, quality control and management, health reform on performance